Replikins explains how an analysis of gene structures in the dengue virus led to the development of a vaccine candidate

How a Genetic Analysis of Dengue Led to the Vaccine Candidate

Replikins explains how an analysis of gene structures in the dengue virus led to the development of a vaccine candidate Replikins Ltd, the company that first identified a group of peptides called Replikins, has announced that one of its studies on the genetic structure of the dengue virus has been instrumental in the development of their synthetic dengue vaccine candidate. …

NIH Establishes Monkey Model for MERS-CoV

An NIH study suggests that marmoset models are the optimum option for testing new drugs for MERS Scientists from the National Institutes of Health have found that the Middle East Respiratory (MERS) virus in marmosets provokes a very similar response to humans afflicted with MERS caused pneumonia. The doctors began testing MERS treatments on marmosets after using computer models to …

Exclusive vaccine delivery interview with Dr Chantal Pichon, University of Orleans and CNRS

The 15th World Vaccine Congress on 13 – 15 October in Brussels is just a few weeks away and I recently sat down with one of our key speakers, Dr Chantal Pichon (Professor, University of Orleans and CNRS Center for Molecular Biophysics) for a short interview. Dr Pichon will be discussing her research in Histidylated-based nanoparticles for mRNA vaccines delivery. …

A new Immunotherapy Technology Developed at Yale University Helps Patients Own Immune Cells Fight Cancer

Immune Cell Cancer Fighting Activity Boosted By Nanomaterials

A new Immunotherapy Technology Developed at Yale University Helps Patients Own Immune Cells Fight Cancer Researchers at Yale University have developed a new technology which uses a sample of a cancer patients immune cells and grows them in the lab, using carbon nanotube-polymer composites. When these enhanced immune cells are injected back into the patients body, the immune cancer-fighting response …

Researchers at Stanford Retract Narcolepsy Study Linked to GSK’s Swine Flu Vaccine

Stanford University researchers have retracted a major study that sought to explain why some abruptly fell asleep after receiving Pandemrix vaccine Researchers at the University of Stanford School of Medicine have retracted a study they published last year which endeavoured to explain why some people were falling asleep after receiving a GSK Swine Flu vaccine called Pandemrix. The researchers behind …

Bettina Klug, PEI: The Future of Genetic Modification in Vaccine Development

The vaccine industry is in a time where there is a lot to be excited about around new developments. However, these new approaches to vaccine development bring significant challenges in terms of bringing them to market. Earlier this year the VaccineNation team were able to sit down with Dr Bettina Klug, Scientific Administrator at the Paul-Ehrlich-Institut to understand her thought …